Table of Contents

company-logo

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington.

Cocrystal Pharma Dividend Announcement

• Cocrystal Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cocrystal Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cocrystal Pharma Dividend History

Cocrystal Pharma Dividend Yield

Cocrystal Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cocrystal Pharma stock? Use our calculator to estimate your expected dividend yield:

Cocrystal Pharma Financial Ratios

P/E ratio-0.99
PEG ratio0.01
P/B ratio1.02
ROE-73.89%
Payout ratio0.00%
Current ratio7.41
Quick ratio7.41
Cash Ratio6.86

Cocrystal Pharma Dividend FAQ

Does Cocrystal Pharma stock pay dividends?
Cocrystal Pharma does not currently pay dividends to its shareholders.
Has Cocrystal Pharma ever paid a dividend?
No, Cocrystal Pharma has no a history of paying dividends to its shareholders. Cocrystal Pharma is not known for its dividend payments.
Why doesn't Cocrystal Pharma pay dividends?
There are several potential reasons why Cocrystal Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cocrystal Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cocrystal Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cocrystal Pharma a dividend aristocrat?
Cocrystal Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cocrystal Pharma a dividend king?
Cocrystal Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cocrystal Pharma a dividend stock?
No, Cocrystal Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cocrystal Pharma stocks?
To buy Cocrystal Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cocrystal Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.